GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Barak Investment House BARI.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

3,801.00

+7.62%

Close of 6 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Barak Investment House

Its shares trade on Tel Aviv under the ticker BARI.TA. It has been listed since 1 August 2006. In the fiscal year to 31 December 2024, it reported revenue of ILS 4.7m and a net loss of ILS 16.1m. At that date it held total assets of ILS 3.4m and shareholders' equity of ILS 1.3m.

Panaxia Labs Israel Ltd. engages in the manufacture and distribution of medical cannabis products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
1 Aug 2006
Employees
146

Leadership

Pay as last reported

  • Mr. Jonathan KolberChairman of the Board, since 2019
  • Dr. David SegalChief Executive Officer, Director, since 2019
  • Ms. Yafa LevyChief Financial Officer
  • Mr. Assi RotbartChief Business Officer, Director, since 2019
  • Dr. Eran GoldbergChief Technology Officer, Vice President
  • Mr. Gil BenyaminiVice President - Finance
  • Mr. Joseph GinossarInternal Auditor
  • Ms. Orit Freedman WeissmanDirector
  • Ms. Tali Yaron-EldarDirector, since 2016
  • Ms. Michal Marom-BrikmanExternal Director
  • Mr. Moshe ReuveniExternal Director
  • Ms. Rinat GazitIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Panaxia Labs Israel Ltd possesses several strengths that contribute to its competitive advantage in the market. These strengths include:

Weaknesses

  • Despite its strengths, Panaxia Labs Israel Ltd also faces several weaknesses that may hinder its growth and performance. These weaknesses include:

Opportunities

  • Panaxia Labs Israel Ltd can leverage the following opportunities to expand its market presence and improve its financial performance:

Threats

  • Panaxia Labs Israel Ltd should be cautious about the following threats that could impact its business operations and market position:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.